The direction matters: SRe changes with direction in a rat model of graded diastolic dysfunction


March 6, 2023
Cardiovascular Research User Forum NORMOLIM User stories

Euro-BioImaging is organizing an online User Forum on Tuesday, March 21, 2023, from 14:00-17:00 CET. The topic is “Cardiovascular research.” This event will highlight the importance of cutting-edge imaging technologies in support of cardiovascular health, disease, diagnostics and the development of therapies. We will showcase the specific expertise available at our Nodes across Europe through case studies presented in tandem with the research community.

At this event, Ida Marie Hauge-Iversen, Oslo University Hospital, will explain how tissue phase mapping (TPM) Cardiac magnetic resonance (CMR) which she performed at the NORMOLIM Node, can be used to assess bidirectional Myocardial strain rate in the early filling phase (SRe), and potentially bring us one step closer to understanding the diastolic function of the heart. 

Hear this talk and others like it on March 21 at the Euro-BioImaging User Forum: Cardiovascular Research.

REGISTER

FULL PROGRAM

Abstract:

Diastolic dysfunction (DD) is an increasing public health problem, where important underlying mechanisms remain unknown. Accurate measures of DD in animal models are crucial for mechanistic research. Myocardial strain rate in the early filling phase (SRe) is closely associated with diastolic function. Cardiac magnetic resonance (CMR) offers unparalleled ability to quantify myocardial deformation rates in any direction. In this study, we utilized tissue phase mapping (TPM) CMR to assess bidirectional SRe in a rat model of graded DD. The aim was to get better knowledge of how DD affects SRe in different directions.

Graded DD was induced in rats by aortic banding (AB), where o-rings with an inner diameter of either 1.3 (n=8) or 1.5mm (n=10) were placed around the ascending aorta. A group with sham-operated rats (n=10) served as control. MRI was performed 20 weeks post-operation, when left ventricle (LV) hypertrophy and myocardial fibrosis were allowed to develop. CMR with TPM and CINE was performed using a 9.4T preclinical CMR system, before tissue was harvested. TPM included a long-axis four-chamber view (for longitudinal SR) and a mid-LV short-axis view (for circumferential SR). CINE included a short-axis stack of the whole LV and left atrium (LA). SRe was calculated from TPM using Matlab. Ex vivo tissue was weighed and analyzed by ddPCR. p-values were found using Kruskal-Wallis with multiple comparison test.

Both AB groups showed signs of DD with increased LV mass, increased BNP expression and preserved EF. In addition, the 1.3 group exhibited higher collagen expression, lung weight and LA volume than the 1.5 group, indicating more severe DD. Longitudinal SRe was lower (p=0.01) in the 1.3 group compared to control, and exhibited a negative correlation to LA volume across all three groups. Circumferential SRe was higher (p=0.01) in the 1.3 group compared to control and showed a positive correlation to LA volume.

We found that with increasing grade of DD, longitudinal SRe is reduced, whereas, interestingly, circumferential SRe is increased. This may indicate that improved circumferential SRe compensate for the loss in longitudinal SRe. Our results demonstrate the importance of the direction in which myocardial deformation rate is measured. Further investigation of this mechanism can potentially bring us one step towards understanding the diastolic function of the heart.


More news from Euro-BioImaging

Scientific Ambassadors activities

December 17, 2024

Celebrating Euro-BioImaging’s Scientific Ambassadors

In March 2024, Euro-BioImaging onboarded the first pilot cohort of Scientific Ambassadors, a group of 12 highly motivated individuals whose dedication and passion for…

December 17, 2024

Highlights from foundingGIDE Community Event 2024

foundingGIDE is a project coordinated by Euro-BioImaging and funded under the European Commission’s Horizon Europe framework program. foundingGIDE is dedicated to enabling the interoperability…

France-BioImaging Annual Meeting 2024 in Strasbourg. Photo courtesy of France-BioImaging.

December 16, 2024

Congratulations, France-BioImaging!

2024 will stand out in France-BioImaging history as a very positive year. Not only was France-BioImaging awarded significant national funding to support their infrastructure…